4:06 PM ET
8-K
Deal Termination
Allarity Therapeutics Deal Termination with Tumim Stone Capital LLC
Allarity Therapeutics terminated its Common Stock Purchase Agreement with Tumim Stone Capital, effective October 28, 2026. The agreement had allowed the company to sell up to $6.0 million of common stock at its discretion, but Allarity elected to cancel the facility to pursue alternative financing arrangements. No early termination penalties were incurred as a result of the cancellation.
- Counterparty
- Tumim Stone Capital LLC